Clinical Trial Update: Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS)) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of naltrexone and methylphenidate for cognition in healthy individuals and in Attention Deficit Hyperactivity …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)
• Naltrexone (Naltrexone)

Snippet

Sponsor: University of Michigan | Conditions: Healthy, Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2018-06-18